Background:
Smoking and obesity are esophageal adenocarcinoma (EAC) risk factors. However, the same risk factors may also affect biological aggressiveness and cancer outcomes. Our study evaluated the combined effects of early-adulthood obesity and cumulative smoking on the EAC survival.
Patients And Methods:
In two EAC cohorts, Toronto (TO; N=235) and Boston (BO; N=329), associations between early adulthood body mass index (EA-BMI), BMI at 1year prior to diagnosis (BMI-1), and smoking with overall survival (OS) were assessed using Cox proportional hazard models, adjusted for relevant covariates.
Results:
Both cohorts were predominantly Caucasian (89%), male (88%), ever-smokers (73%) with locally advanced/metastatic EAC (78%), and good ECOG performance status (90%); median packyears was 34; median EA-BMI, 24; median BMI-1, 25. No relationships with survival were found with BMI-1. For smoking and EA-BMI, TO, BO, and combined TO-BO analyses showed similar associations: smoking conferred worse OS in the combined TO-BO cohort, with adjusted hazard ratios (aHR) of 1.22 (95%CI: 1.15-1.43;p<0.0001) for each 20 pack-year increase. Likewise, EA-BMI ≥25 was associated with worse OS (EA-BMI of 25-<30, aHR=1.84,95%CI: 1.37-2.48; and EA-BMI>30, aHR=2.78, 95%CI: 1.94-3.99). Risk of death was also increased in remotely underweight patients with EA-BMI<18.5 (aHR=2.03,95%CI: 1.27-3.24), when compared to normal-EA-BMI (18≤EA-BMI<25).
Conclusions:
Two key modifiable behaviors, elevated BMI in early adulthood and heavy cumulative smoking history are independently associated with increased mortality risk in two North American cohorts of EAC patients.
Citing Articles
Long-term survival and risk factors in esophageal squamous cell carcinoma: A Kaplan-Meier and cox regression study.
Ren Z, Kang M, Zhu L, Li P
World J Gastrointest Surg. 2024; 16(12):3772-3779.
PMID: 39734461
PMC: 11650227.
DOI: 10.4240/wjgs.v16.i12.3772.
Gastroesophageal Disease and Environmental Exposure: A Systematic Review.
Kim D, Podury S, Zadeh A, Kwon S, Grunig G, Liu M
Res Sq. 2024; .
PMID: 39149446
PMC: 11326364.
DOI: 10.21203/rs.3.rs-4650430/v1.
Influence of radiotherapy interruption on esophageal cancer with intensity-modulated radiotherapy: a retrospective study.
Mou Y, Liang P, Cheng X, He X, Zhang J, Liu L
BMC Cancer. 2024; 24(1):646.
PMID: 38802765
PMC: 11129380.
DOI: 10.1186/s12885-024-12383-7.
Clinical and Lifestyle-Related Prognostic Indicators among Esophageal Adenocarcinoma Patients Receiving Treatment at a Comprehensive Cancer Center.
Dighe S, Yan L, Mukherjee S, McGillicuddy C, Hulme K, Hochwald S
Cancers (Basel). 2021; 13(18).
PMID: 34572881
PMC: 8465866.
DOI: 10.3390/cancers13184653.
Association of Obesity With Survival Outcomes in Patients With Cancer: A Systematic Review and Meta-analysis.
Petrelli F, Cortellini A, Indini A, Tomasello G, Ghidini M, Nigro O
JAMA Netw Open. 2021; 4(3):e213520.
PMID: 33779745
PMC: 8008284.
DOI: 10.1001/jamanetworkopen.2021.3520.
Clinical characteristics and survival of 5283 esophageal cancer patients: A multicenter study from eighteen hospitals across six regions in China.
He Y, Liang D, Du L, Guo T, Liu Y, Sun X
Cancer Commun (Lond). 2020; 40(10):531-544.
PMID: 32845581
PMC: 7571391.
DOI: 10.1002/cac2.12087.
Augmenting cancer registry data with health survey data with no cases in common: the relationship between pre-diagnosis health behaviour and post-diagnosis survival in oesophageal cancer.
Fahey P, Page A, Stone G, Astell-Burt T
BMC Cancer. 2020; 20(1):496.
PMID: 32487049
PMC: 7268470.
DOI: 10.1186/s12885-020-06990-3.
Using estimated probability of pre-diagnosis behavior as a predictor of cancer survival time: an example in esophageal cancer.
Fahey P, Page A, Stone G, Astell-Burt T
BMC Med Res Methodol. 2020; 20(1):74.
PMID: 32245417
PMC: 7118984.
DOI: 10.1186/s12874-020-00957-5.
Prediagnostic adult body mass index change and esophageal adenocarcinoma survival.
Loehrer E, Giovannucci E, Betensky R, Shafer A, Christiani D
Cancer Med. 2020; 9(10):3613-3622.
PMID: 32202699
PMC: 7221446.
DOI: 10.1002/cam4.3015.
Alcohol intake, tobacco smoking, and esophageal adenocarcinoma survival: a molecular pathology epidemiology cohort study.
McCain R, McManus D, McQuaid S, James J, Salto-Tellez M, Reid N
Cancer Causes Control. 2019; 31(1):1-11.
PMID: 31786674
PMC: 6942597.
DOI: 10.1007/s10552-019-01247-2.
Diabetes in relation to Barrett's esophagus and adenocarcinomas of the esophagus: A pooled study from the International Barrett's and Esophageal Adenocarcinoma Consortium.
Petrick J, Li N, Anderson L, Bernstein L, Corley D, El Serag H
Cancer. 2019; 125(23):4210-4223.
PMID: 31490550
PMC: 7001889.
DOI: 10.1002/cncr.32444.
Nomogram predicting cancer-specific mortality in patients with esophageal adenocarcinoma: a competing risk analysis.
Wu X, Chen R, Chen R, Gong H, Wang B, Li Y
J Thorac Dis. 2019; 11(7):2990-3003.
PMID: 31463129
PMC: 6687980.
DOI: 10.21037/jtd.2019.07.56.
Clinical significance of tumor necrosis factor receptor 2 in middle and lower thoracic esophageal squamous cell carcinoma.
Yang D, Li R, Wang H, Wang J, Li Y, Wang H
Oncol Lett. 2018; 16(3):2971-2978.
PMID: 30127886
PMC: 6096069.
DOI: 10.3892/ol.2018.8998.
Bile acid and cigarette smoke enhance the aggressive phenotype of esophageal adenocarcinoma cells by downregulation of the mitochondrial uncoupling protein-2.
Xu Y, Feingold P, Surman D, Brown K, Xi S, Davis J
Oncotarget. 2017; 8(60):101057-101071.
PMID: 29254145
PMC: 5731855.
DOI: 10.18632/oncotarget.22380.